• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Lupin receives approval from US FDA for Meclizine Hydrochloride Tablets USP

    EXPRESS PHARMA

    Lupin`s Generic Meclizine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of April 6, 2022

    FDA

    Invagen Pharms` Generic Meclizine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of October 13, 2021

    FDA

    Enforcement Report - Week of February 24, 2021

    FDA

    Zydus Pharms`s Generic Meclizine Hydrochloride Receives Approval in US

    FDA

    Zydus Cadila gets USFDA nod to market generic antihistamine tablets

    MONEYCONTROL

    Enforcement Report - Week of November 20, 2019

    FDA

    Enforcement Report - Week of November 22, 2017

    FDA

    Formulation and Evaluation of Meclizine Hcl Orally Dispersible Tablets

    PHARMA-EXCIPIENTS

    Formulation, Development and Evaluation of Meclozine Hydrochloride Microspheres

    PHARMA-EXCIPIENTS

    Golden State Medical Supply recalls Meclizine HCl(12.5 mg) due to Out of spec

    FDA

    Golden State Medical Supply recalls Meclizine HCL(25 mg) due to Out of spec

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.